153 related articles for article (PubMed ID: 31233753)
1. Anti-colorectal cancer biotargets and biological mechanisms of puerarin: Study of molecular networks.
Li J; Guo C; Lu X; Tan W
Eur J Pharmacol; 2019 Sep; 858():172483. PubMed ID: 31233753
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study.
Liang Y; Zhou R; Liang X; Kong X; Yang B
Eur J Pharmacol; 2020 Aug; 881():173227. PubMed ID: 32505664
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses.
Li R; Song Y; Ji Z; Li L; Zhou L
Biofactors; 2020 Jan; 46(1):158-167. PubMed ID: 31647596
[TBL] [Abstract][Full Text] [Related]
4. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
Huang C; Li R; Shi W; Huang Z
Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
[TBL] [Abstract][Full Text] [Related]
5. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
[TBL] [Abstract][Full Text] [Related]
6. Anti-Colorectal Cancer Mechanisms of Formononetin Identified by Network Pharmacological Approach.
Zhang L; Gong Y; Wang S; Gao F
Med Sci Monit; 2019 Oct; 25():7709-7714. PubMed ID: 31608899
[TBL] [Abstract][Full Text] [Related]
7. Puerarin induced in mantle cell lymphoma apoptosis and its possible mechanisms involving multi-signaling pathway.
Gan M; Yin X
Cell Biochem Biophys; 2015 Jan; 71(1):367-73. PubMed ID: 25173778
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
[TBL] [Abstract][Full Text] [Related]
9. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activities of a benzimidazole compound through sirtuin inhibition in colorectal cancer.
Tan YJ; Lee YT; Yeong KY; Petersen SH; Kono K; Tan SC; Oon CE
Future Med Chem; 2018 Sep; 10(17):2039-2057. PubMed ID: 30066578
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer targets of formononetin and molecular mechanisms in osteosarcoma: Findings of bioinformatic and experimental assays.
Hu W; Wu X; Tang J; Zhao G; Xiao N; Zhang L; Li S
J Cell Mol Med; 2019 May; 23(5):3505-3511. PubMed ID: 30873755
[TBL] [Abstract][Full Text] [Related]
13. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
[TBL] [Abstract][Full Text] [Related]
14. Down-Regulated LncRNA-HOTAIR Suppressed Colorectal Cancer Cell Proliferation, Invasion, and Migration by Mediating p21.
Lin K; Jiang H; Zhang LL; Jiang Y; Yang YX; Qiu GD; She YQ; Zheng JT; Chen C; Fang L; Zhang SY
Dig Dis Sci; 2018 Sep; 63(9):2320-2331. PubMed ID: 29808247
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of colorectal cancer patients and anti-neoplasm activity of genistein.
Chen X; Gu J; Wu Y; Liang P; Shen M; Xi J; Qin J
Biomed Pharmacother; 2020 Apr; 124():109835. PubMed ID: 31958764
[TBL] [Abstract][Full Text] [Related]
16. Puerarin inhibits vascular smooth muscle cells proliferation induced by fine particulate matter via suppressing of the p38 MAPK signaling pathway.
Wan Q; Liu Z; Yang Y
BMC Complement Altern Med; 2018 May; 18(1):146. PubMed ID: 29728095
[TBL] [Abstract][Full Text] [Related]
17. Calycosin induces apoptosis by the regulation of ERβ/miR-17 signaling pathway in human colorectal cancer cells.
Chen J; Zhao X; Li X; Wu Y
Food Funct; 2015 Sep; 6(9):3091-7. PubMed ID: 26215320
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of puerarin on vascular smooth muscle cells proliferation induced by oxidised low-density lipoprotein via suppressing ERK 1/2 phosphorylation and PCNA expression.
Hu Y; Liu K; Bo S; Yan M; Zhang Y; Miao C; Ren L
Pharmazie; 2016 Feb; 71(2):89-93. PubMed ID: 27004373
[TBL] [Abstract][Full Text] [Related]
19. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
20. Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data.
Li R; Ma X; Song Y; Zhang Y; Xiong W; Li L; Zhou L
J Cell Biochem; 2019 Jul; 120(7):11265-11273. PubMed ID: 30719773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]